Hospira Company Profile

✉ Email this page to a colleague

HOSPIRA has five hundred and eighteen approved drugs.

There are nine US patents protecting HOSPIRA drugs. There are seven tentative approvals on HOSPIRA drugs.

There are sixty-nine patent family members on HOSPIRA drugs in thirty-eight countries and four hundred and nineteen supplementary protection certificates in sixteen countries.

International Patents:	69
US Patents:	9
Tradenames:	333
Ingredients:	210
NDAs:	518
Patent Litigation for Hospira:	See patent lawsuits for Hospira
PTAB Cases with Hospira as petitioner:	See PTAB cases with Hospira as petitioner

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hospira	TAZICEF	ceftazidime	INJECTABLE;INJECTION	062662-004	Mar 6, 1986	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Hospira Inc	THEOPHYLLINE IN DEXTROSE 5% IN PLASTIC CONTAINER	theophylline	INJECTABLE;INJECTION	019211-004	Dec 14, 1984		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Hospira	LEUCOVORIN CALCIUM	leucovorin calcium	INJECTABLE;INJECTION	008107-004	May 23, 1988		DISCN	Yes	No		⤷ Try a Trial				⤷ Try a Trial
Hospira	FUROSEMIDE	furosemide	INJECTABLE;INJECTION	072080-001	Aug 13, 1991		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Hospira Inc	CEFTRIAXONE	ceftriaxone sodium	INJECTABLE;INTRAMUSCULAR, INTRAVENOUS	065230-002	Aug 2, 2005		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Hospira	BIVALIRUDIN	bivalirudin	INJECTABLE;INTRAVENOUS	090816-001	Jul 14, 2015	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Hospira	PRECEDEX	dexmedetomidine hydrochloride	INJECTABLE;INJECTION	021038-001	Dec 17, 1999	4,910,214*PED	⤷ Try a Trial
Hospira	BRETYLOL	bretylium tosylate	INJECTABLE;INJECTION	017954-001	Approved Prior to Jan 1, 1982	RE29618	⤷ Try a Trial
Hospira	PRECEDEX	dexmedetomidine hydrochloride	INJECTABLE;INJECTION	021038-003	Mar 13, 2013	6,716,867*PED	⤷ Try a Trial
Hospira	TRACRIUM PRESERVATIVE FREE	atracurium besylate	INJECTABLE;INJECTION	018831-001	Nov 23, 1983	4,179,507	⤷ Try a Trial
Hospira	PRECEDEX	dexmedetomidine hydrochloride	INJECTABLE;INJECTION	021038-001	Dec 17, 1999	6,716,867*PED	⤷ Try a Trial
Hospira	PRECEDEX	dexmedetomidine hydrochloride	INJECTABLE;INJECTION	021038-001	Dec 17, 1999	5,344,840	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Injection	100 mcg/mL	➤ Subscribe	2009-04-08
➤ Subscribe	Injection	4 mcg/mL, 20 mL vials	➤ Subscribe	2015-09-30
➤ Subscribe	Injection	1 mg/mL, 50 mL vials	➤ Subscribe	2011-12-16
➤ Subscribe	Injection	4 mcg/mL, 50 mL and 100 mL vials	➤ Subscribe	2013-12-26
➤ Subscribe	Injection	100 mg/mL, 2.5 mL vials	➤ Subscribe	2007-09-24

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
3412676	PA2020519	Lithuania	⤷ Try a Trial	PRODUCT NAME: VABORBAKTAMO IR (ARBA) JO DRUSKOS, IR (ARBA) HIDRATO BEI MEROPENEMO IR (ARBA) JO DRUSKOS, IR (ARBA) HIDRATO, YPAC MEROPENEMO TRIHIDRATO, DERINYS; REGISTRATION NO/DATE: EU/1/18/1334 20181120
1411900	2011C/016	Belgium	⤷ Try a Trial	PRODUCT NAME: NAPROXENE ET ESOMEPRAZOLE (SOUS LA FORME D'ESOMEPRAZOLE MAGNESIUM TRIHYDRATE); AUTHORISATION NUMBER AND DATE: BE382505 20101214
2365988	LUC00061	Luxembourg	⤷ Try a Trial	PRODUCT NAME: PATIROMER SORBITEX CALCIUM ET TOUS LES SELS ET DERIVES DE CELUI-CI; AUTHORISATION NUMBER AND DATE: EU/1/17/1179 20170721
0392059	0290025-6	Sweden	⤷ Try a Trial	PRODUCT NAME: MEMANTIN, 1-AMINO-3,5-DIMETYLADAMANTAN; REGISTRATION NO/DATE: EU/1/02/219/001 20020515
2666774	122020000036	Germany	⤷ Try a Trial	PRODUCT NAME: RELEBACTAM, ODER RELEBACTAM IN FORM DES MONOHYDRATES, IMIPENEM UND CILASTATIN ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON; REGISTRATION NO/DATE: EU/1/19/1420 20200213
0984957	300483	Netherlands	⤷ Try a Trial	PRODUCT NAME: NAXOPREN EN ESOMEPRAZOL ALS MAGNESIUMTRIHYDRAAT; NATIONAL REGISTRATION NO/DATE: RVG 106235 20101118; FIRST REGISTRATION: GB PL 17091/0263 - 0001 20101105
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.